3.70
price up icon3.06%   0.11
after-market After Hours: 3.64 -0.06 -1.62%
loading
Rani Therapeutics Holdings Inc stock is currently priced at $3.70, with a 24-hour trading volume of 17,281. It has seen a +3.06% increased in the last 24 hours and a -7.50% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $3.50 pivot point. If it approaches the $3.76 resistance level, significant changes may occur.
Previous Close:
$3.59
Open:
$3.6
24h Volume:
17,281
Market Cap:
$97.32M
Revenue:
$3.04M
Net Income/Loss:
$-33.97M
P/E Ratio:
-2.6812
EPS:
-1.38
Net Cash Flow:
$-52.47M
1W Performance:
-1.07%
1M Performance:
-7.50%
6M Performance:
+8.82%
1Y Performance:
-12.94%
1D Range:
Value
$3.60
$3.75
52W Range:
Value
$1.82
$8.75

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
Name
Rani Therapeutics Holdings Inc
Name
Phone
(408) 457-3700
Name
Address
2051 RINGWOOD AVENUE, SAN JOSE
Name
Employee
140
Name
Twitter
Name
Next Earnings Date
2024-05-29
Name
Latest SEC Filings
Name
RANI's Discussions on Twitter

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-17-23 Resumed BTIG Research Buy
Oct-11-22 Initiated UBS Buy
Jul-27-22 Initiated H.C. Wainwright Buy
Jun-13-22 Initiated Wedbush Outperform

Rani Therapeutics Holdings Inc Stock (RANI) Financials Data

Rani Therapeutics Holdings Inc (RANI) Revenue 2024

RANI reported a revenue (TTM) of $3.04 million for the quarter ending June 30, 2021.
loading

Rani Therapeutics Holdings Inc (RANI) Net Income 2024

RANI net income (TTM) was -$33.97 million for the quarter ending December 31, 2023, a -11.06% decrease year-over-year.
loading

Rani Therapeutics Holdings Inc (RANI) Cash Flow 2024

RANI recorded a free cash flow (TTM) of -$52.47 million for the quarter ending December 31, 2023, a -9.00% decrease year-over-year.
loading

Rani Therapeutics Holdings Inc (RANI) Earnings per Share 2024

RANI earnings per share (TTM) was -$1.33 for the quarter ending December 31, 2023, a -3.91% decline year-over-year.
loading
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
$152.17
price up icon 1.11%
$85.02
price up icon 1.32%
$27.05
price up icon 3.09%
$84.95
price up icon 0.30%
$466.42
price up icon 1.02%
$260.51
price down icon 0.20%
Cap:     |  Volume (24h):